Latest Rotavirus Stories
LONDON, June 13, 2011 /PRNewswire/ -- - GAVI Alliance Poised to IMMUNISE More Than 250 Million Children in Developing Countries by 2015 Major public and private donors achieved a milestone in global health today by committing funding to immunise more than 250 million of the world's poorest children against life-threatening diseases by 2015 and prevent more than four million premature deaths. (Photo: http://www.newscom.com/cgi-bin/prnh/20110613/461374 )...
LONDON, June 13, 2011 /PRNewswire-USNewswire/ -- Dr. Rajiv Shah, Administrator of the U.S. Agency for International Development (USAID), released the following statement to announce an increased U.S.
Rotavirus vaccination in all areas of Brazil is associated with reduced diarrhea-related deaths and hospital admissions in children aged under five years, reports a study in this week's PLoS Medicine.
DEERFIELD, Illinios, February 4, 2011 /PRNewswire/ -- The first assessment of the total cost of dengue illness in the Americas reveals the economic burden to be approximately $2.1 billion per year, exceeding that from other viral illnesses including human papillomavirus (HPV) and rotavirus.
A report has shown that vaccinating babies against rotavirus has significantly reduced the number of children that have been hospitalized due to the disease.
LONDON, December 1, 2010 /PRNewswire/ -- PepTcell, a leading UK privately-owned drug-discovery group, today announced it is changing its name to SEEK. Gregory Stoloff, Chief Executive Officer, explains: "SEEK has a significant number of potential blockbuster assets in different legal entities and we wanted to give them a common identity and purpose.
BOSTON and GRAFTON, Mass., Nov 19, 2010 /PRNewswire-USNewswire/ -- Researchers have developed a promising new approach to vaccination for rotavirus, a common cause of severe diarrheal disease that is responsible for approximately 500,000 deaths among children in the developing world every year.
Researchers have developed a promising new approach to vaccination for rotavirus, a common cause of severe diarrheal disease that is responsible for approximately 500,000 deaths among children in the developing world every year.
PHILADELPHIA, May 14 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced that the Food and Drug Administration (FDA) has determined that U.S. healthcare practitioners can resume the use of RotarixÂ® (Rotavirus Vaccine, Live, Oral), effective immediately.
Rotavirus is the most common cause of diarrhea among infants and young children and is one of several viruses that cause the stomach flu. It is in the family Reoviridae and is a genus of double-stranded RNA. Most children have been infected by the age of five. Each infection builds on previous immunity and thus subsequent infections are less severe and adults are rarely affected. The fives species of the virus are referred to as A, B, C, D, and E. Type A, which is the most common, causes more...
- Of or relating to good digestion.